课题基金 / 基金详情

Medications Development Clinical Trials Network for the Treatment of Alcohol Use Disorder - Contract Research Organization

Medications Development Clinical Trials Network for the Treatment of Alcohol Use Disorder - Contract Research Organization
治疗酒精使用障碍的药物开发临床试验网络 - 合同研究组织
批准号:
10506189
负责人:
JANET RANSOM
金额:
$196.74万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
已结题
起止时间:
2021-06-11 至 2023-06-10

项目摘要

项目成果

JANET RANSOM的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Medications development is a high priority program at National Institute on Alcohol Abuse and Alcoholism (NIAAA). Currently, only three medications are approved by the Food and Drug Administration (FDA) for the treatment of alcohol use disorder (AUD). These medications have demonstrated small to moderate effect sizes in clinical trials and do not work for everyone, making the search for new molecular targets and more efficacious pharmacotherapies critical. The purpose of the current contract is to support a Contract Research Organization (CRO) to conduct all aspects of multiple, multi-center, pharmacotherapy clinical trials for the treatment of AUD.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ALCOHOL CUE LABORATORY STUDY TESTING ANS-6637 - CONTRACT RESEARCH ORGANIZATION STUDY AND DATA MANAGEMENT
  • 批准号:
    10037755
  • 项目类别:
  • 资助金额:
    $192.16万
  • 财政年份:
    2019
  • 负责人:
    JANET RANSOM
  • 依托单位:
IGF::OT::IGF CLINICAL TRIAL
海外基金